An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia

Archives of Ophthalmology

Volumn 115, Issue 8, 1997, Pages 1036-1047

  Frank, Robert N ^a   Amin, Rajesh ^a   Kennedy, Alexander ^a   Hohman, Thomas C ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; BLOOD CLOTTING FACTOR 8; GALACTITOL; GALACTOSE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMOGLOBIN; VASCULOTROPIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIETARY INTAKE; GALACTOSEMIA; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; RETINA NEOVASCULARIZATION; SCIATIC NERVE;

EID: 0030839689     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160206011     Document Type: Article

References (34)

1. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl JMed. 1994;331:1480-1487.
2. Adamis AP, Miller JW, Bernai M-T, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
3. Pe'er J, Shweiki D, Itin A, Memo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factorlike activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994;112:1476-1482.
4. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994;112:1476-1482.
5. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/ vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
6. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995;92:905-909.
7. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995;92:10457-10461.
8. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol. 1996;114:66-71.
9. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A. 1996;93:4851-4856.
10. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by
11. hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
12. Henkind P. Ocular neovascularization. Am J Ophlhalmol. 1978;85:287-301.
13. Patz A. Studies on retinal neovascularization. Invest Ophthalmol Vis Sci. 1980; 19:1133-1138.
14. Robison WG Jr, Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabeticlike retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Ms Sa 1989;30:2285-2292.
15. Kern TS, Engerman RL Galactose-induced retinal microangiopathy in rats. Invest Ophthalmol Vis Sci. 1995;36:490-496.
16. Kohner EM, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol. 1970;69:403-414.
17. Hammes H-P, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA. 1991;88:11555-11558.
18. Kuwabara T, Cogan DG. Studies of retinal vascular patterns, part I: normal architecture. Arch Ophthalmol. 1960;64:904-911.
19. Laver NM, Robison WG Jr, Pfeffer BA. Novel procedures for isolating intact retinal vascular beds from diabetic humans and animal models. Invest Ophthalmol issScJ. 1993;34:2097-2104.
20. Robison WG Jr, Laver NM, Jacot JL, et al. Diabeticlike retinopathy ameliorated with the aldose reductase inhibitorWAY-121,509. InvestOphhalmol Vis Sci. 1996; 37:1149-1156.
21. Guerrant GO, Moss CW. Determination of monosaccharides as aldonitrile O-methyloxime, alditol and cyclitol acetate derivatives by gas chromatography. Anal Chem. 1984;56:633-638.
22. Van Kampel EJ, Zijlstra WG. Standardization of hemoglobinometry, II: the hemoglobin cyanide method. Clin ChemActa. 1961;6:538-544.
23. Cogan DG, Toussaint D, Kuwabara T. Studies of retinal vascular patterns, IV: diabetic retinopathy. Arch Ophthalmol. 1961;66:366-378.
24. Bignami A, Dahl D. The radial glia of Müller in the rat retina and their response to injury: an immunofluorescence study with antibodies to the glial fibrillary acidic (GFA) protein. Exp Eye Res. 1979;28:63-69.
25. . 24. Lewis GP, Matsumoto B, Fisher SK. Changes in the organization and expression of cytoskeletal proteins during retinal degeneration induced by retinal detachment. Invest Ophthalmol Vis Sci. 1995;36:2404-2416.
26. Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes. 1987;36:808-812.
27. Engerman RL, Kern TS. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. Arch Ophtha/mol. 1994;113:355-358.
28. Lerman S. Carbohydrate metabolism in the rat lens as related to the age of the animal. Arch Ophthalmol. 1961;65:181-183.
29. Kim I, Tolentino MJ, Miller JW, Adamis AP. Constitutive VEGF mRNA expression in the tissues of normal adult eyes. Invest Ophtha/mol Vis Sci. 1996;37: S792. ARVO Abstract.
30. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
31. Amin RH, Frank RN, Kennedy A, Eliott E, Puklin JE, Abrams GW. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38:36-47.
32. Lutty GA, McLeod DS, Merges C, Diggs A, Plouét J. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996; 114:971-977.
33. Frank RN, Keirn RJ, Kennedy A, Frank KW. Galactose-induced retinal capillary basement membrane thickening: prevention by sorbinil. Invest Ophthalmol Vis Sci. 1983;24:1519-1524.
34. Robison WG Jr, Kador PF, Kinoshita JH. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science. 1983;221:1177-1179.